
Pubmed-entry ::= {
  pmid 28825071,
  medent {
    em std {
      year 2017,
      month 8,
      day 22,
      hour 6,
      minute 0
    },
    cit {
      title {
        name "Enhanced cancer therapy by the marriage of metabolic alteration
 and mitochondrial-targeted photodynamic therapy using cyclometalated Ir(iii)
 complexes."
      },
      authors {
        names std {
          {
            name ml "Liu J",
            affil str "MOE Key Laboratory of Bioinorganic and Synthetic
 Chemistry, School of Chemistry, Sun Yat-Sen University, Guangzhou, 510275, P.
 R. China. ceschh@mail.sysu.edu.cn."
          },
          {
            name ml "Jin C"
          },
          {
            name ml "Yuan B"
          },
          {
            name ml "Chen Y"
          },
          {
            name ml "Liu X"
          },
          {
            name ml "Ji L"
          },
          {
            name ml "Chao H"
          }
        }
      },
      from journal {
        title {
          iso-jta "Chem. Commun. (Camb.)",
          ml-jta "Chem Commun (Camb)",
          issn "1364-548X",
          name "Chemical communications (Cambridge, England)"
        },
        imp {
          date std {
            year 2017,
            month 8,
            day 31
          },
          volume "53",
          issue "71",
          pages "9878-9881",
          language "eng",
          pubstatus ppublish,
          history {
            {
              pubstatus pubmed,
              date std {
                year 2017,
                month 8,
                day 22,
                hour 6,
                minute 0
              }
            },
            {
              pubstatus medline,
              date std {
                year 2017,
                month 8,
                day 22,
                hour 6,
                minute 1
              }
            },
            {
              pubstatus other,
              date std {
                year 2017,
                month 8,
                day 22,
                hour 6,
                minute 0
              }
            }
          }
        }
      },
      ids {
        pubmed 28825071,
        doi "10.1039/c7cc05518h",
        other {
          db "ELocationID doi",
          tag str "10.1039/c7cc05518h"
        }
      }
    },
    abstract "Herein we present a series of DCA-Ir(iii) co-drug complexes that
 preferentially accumulate in mitochondria and selectively cause cancer cell
 metabolic alterations and were found to act in synergy by sensitizing cancer
 cells for PDT to achieve cancer-specific enhanced two-photon PDT in the
 hypoxic environment of multicellular tumor spheroids.",
    pmid 28825071,
    pub-type {
      "Journal Article"
    },
    status premedline
  }
}


